Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Digestive Diseases (Basel, Switzerland)|January 1, 1992
Prevention of upper gastrointestinal bleeding from portal hypertension in cirrhosis: rationale for medical treatmentL Pagliaro, G D'Amico, F Tinè, et al.The New England Journal of Medicine|May 30, 1991
Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study GroupT Poynard, P Calès, L Pasta, et al.Bollettino Dell'Istituto Sieroterapico Milanese|January 31, 1979
[Observations on the diffusion of hepatitis A and B virus during an epidemic in a Sicilian town with a high rate of infection]G D'Amico, L Dardanoni, V Gulì, et al.Journal of Hepatology|February 1, 1994
Terlipressin or vasopressin plus transdermal nitroglycerin in a treatment strategy for digestive bleeding in cirrhosis. A randomized clinical trial. Liver Study Group of V. Cervello HospitalG D'Amico, M Traina, G Vizzini, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 3, 2004
C4BQ0: a genetic marker of familial HCV-related liver cirrhosisL Pasta, G Pietrosi, C Marrone, et al.Hepatology (Baltimore, Md.)|October 31, 1998
Octreotide compared with placebo in a treatment strategy for early rebleeding in cirrhosis. A double blind, randomized pragmatic trialG D'Amico, F Politi, A Morabito, et al.Hepatology (Baltimore, Md.)|February 15, 2001
Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection?F Schepis, C Cammà, D Niceforo, et al.Alimentary Pharmacology & Therapeutics|March 25, 2014
Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patientsG D'Amico, L Pasta, A Morabito, et al.Pageof 1